Investment
Features
FeesSafety
Academy
More
Pluang+

US House panel to vote on bill creating a 20-year Strategic Bitcoin Reserve.

Market News
15 Sep 2026
Crypto news
View Source
Bullish
US House panel to vote on bill creating a 20-year Strategic Bitcoin Reserve.

The US House Financial Services Committee will mark up H.R. 8957 on Sept. 16, a bill to establish a Strategic Bitcoin Reserve requiring government-held Bitcoin to be locked for at least 20 years. The bill mandates quarterly public proof-of-reserve reports and creates a separate stockpile for non-Bitcoin digital assets. Treasury and Commerce will study budget-neutral ways to acquire more Bitcoin without new taxes or borrowing. The legislation also allows states to voluntarily place Bitcoin in segregated federal accounts and protects private ownership rights of digital assets.

The Strategic Bitcoin Reserve bill is set for a House committee vote on September 16. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 15, 2026 14:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 18 rose and 31 fell today. Notable movers include XLM (Stellar) at Rp3.400 with a 1-day change of +4.65% and a typical hold time of 83 days, YFI (yearn.finance) at Rp37.618.392 down 4.65%, and GRT (The Graph) at Rp318 down 4.00%.

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
2 hours ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
2 hours ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
3 hours ago
XRP market value drops $61B in a year as Evernorth launches XRP treasury company on Nasdaq

XRP market value drops $61B in a year as Evernorth launches XRP treasury company on Nasdaq

XRP's circulating market value fell by $61.14 billion, or 42.64%, from $143.38 billion on Oct. 19, 2025, to $82.24 billion a year later, driven by a price drop from $2.39 to $1.30 despite a slight increase in circulating supply. Meanwhile, Evernorth ...

Market News
Neutral
4 hours ago
Remitly's revenue grows 20% with strong product expansion, yet valuation undervalues its potential.

Remitly's revenue grows 20% with strong product expansion, yet valuation undervalues its potential.

Remitly reported a 20% year-over-year revenue increase to $495 million, supported by 10.2 million active customers and a 197% rise in Free Cash Flow. The company is expanding its product offerings with the Remitly Card and Pay Later services, which, ...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App